Citation Impact

Citing Papers

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
2013
Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients
2013
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections
2016
Determining a clinical framework for use of cefepime and  -lactam/ -lactamase inhibitors in the treatment of infections caused by extended-spectrum- -lactamase-producing Enterobacteriaceae
2013
Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria
2015
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
An Emerging Clone (ST457) ofAcinetobacter baumanniiClonal Complex 92 With Enhanced Virulence and Increasing Endemicity in South China
2018
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options
2015
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout

Works of Ryan Tansek being referenced

Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: A Monte Carlo simulation model
2014
The carbapenem-resistant Enterobacteriaceae score: A bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients
2012
Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
2012
Rankless by CCL
2026